Incannex Healthcare Inc. IXHL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | 0.00 |
| SG&A Expenses | 3.70M | 3.73M | 4.72M | 5.67M | 3.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.49M | 3.97M | 6.51M | 6.41M | 7.96M |
| Operating Income | -1.49M | -3.97M | -6.51M | -6.41M | -7.96M |
| Income Before Tax | -2.49M | -3.88M | -6.52M | -6.41M | -31.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.49M | -3.88M | -6.52M | -6.41M | -31.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.49M | -3.88M | -6.52M | -6.41M | -31.60M |
| EBIT | -1.49M | -3.97M | -6.51M | -6.41M | -7.96M |
| EBITDA | -1.44M | -3.90M | -6.45M | -6.34M | -7.90M |
| EPS Basic | -0.20 | -0.31 | -0.56 | -0.62 | -11.41 |
| Normalized Basic EPS | -0.13 | -0.20 | -0.35 | -0.39 | -7.02 |
| EPS Diluted | -0.20 | -0.31 | -0.56 | -0.62 | -11.41 |
| Normalized Diluted EPS | -0.13 | -0.20 | -0.35 | -0.39 | -7.02 |
| Average Basic Shares Outstanding | 12.28M | 12.35M | 11.65M | 10.34M | 2.77M |
| Average Diluted Shares Outstanding | 12.28M | 12.35M | 11.65M | 10.34M | 2.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |